Product NDC: | 55648-992 |
Proprietary Name: | Ziprasidone hydrochloride |
Non Proprietary Name: | Ziprasidone hydrochloride |
Active Ingredient(s): | 40 mg/1 & nbsp; Ziprasidone hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55648-992 |
Labeler Name: | Wockhardt Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090348 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120901 |
Package NDC: | 55648-992-01 |
Package Description: | 30 CAPSULE in 1 BOTTLE (55648-992-01) |
NDC Code | 55648-992-01 |
Proprietary Name | Ziprasidone hydrochloride |
Package Description | 30 CAPSULE in 1 BOTTLE (55648-992-01) |
Product NDC | 55648-992 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ziprasidone hydrochloride |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20120901 |
Marketing Category Name | ANDA |
Labeler Name | Wockhardt Limited |
Substance Name | ZIPRASIDONE HYDROCHLORIDE |
Strength Number | 40 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Atypical Antipsychotic [EPC],Atypical Antipsychotic [EPC] |